The Enterprise Value as of October 2024 (TTM) for Emergent BioSolutions Inc. (EBS) is 1.30B

According to Emergent BioSolutions Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.30B. This represents a change of 47.14% compared to the average of 883.17M of the last 4 quarters.

Emergent BioSolutions Inc. (EBS) Historical Enterprise Value (quarterly & annually)

How has EBS Enterprise Value performed in the past?

The mean historical Enterprise Value of Emergent BioSolutions Inc. over the last ten years is 2.25B. The current 1.30B Enterprise Value has changed 5.69% with respect to the historical average. Over the past ten years (40 quarters), EBS's Enterprise Value was at its highest in in the September 2020 quarter at 5.94B. The Enterprise Value was at its lowest in in the September 2023 quarter at 501.92M.

Emergent BioSolutions Inc. (EBS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Emergent BioSolutions Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Emergent BioSolutions Inc. (EBS) Average Enterprise Value

How has EBS Enterprise Value performed in the past?

The current Enterprise Value of Emergent BioSolutions Inc. (EBS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Emergent BioSolutions Inc. (EBS) Enterprise Value vs. Peers

How is EBS’s Enterprise Value compared to its peers?

Emergent BioSolutions Inc.’s Enterprise Value is less than Zoetis Inc. (91.70B), greater than PetIQ, Inc. (1.29B), less than Bausch Health Companies Inc. (24.10B), less than Neurocrine Biosciences, Inc. (12.11B), greater than Akanda Corp. (6.67M), greater than Lifecore Biomedical, Inc. (308.75M), less than Prestige Consumer Healthcare Inc. (4.65B), less than Intra-Cellular Therapies, Inc. (7.64B), greater than Indivior PLC (1.09B), less than Alkermes plc (4.50B), greater than Cumberland Pharmaceuticals Inc. (22.27M), less than Deciphera Pharmaceuticals, Inc. (2.15B), less than Collegium Pharmaceutical, Inc. (1.64B), greater than DURECT Corporation (39.53M),

Build a custom stock screener for Emergent BioSolutions Inc. (EBS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Emergent BioSolutions Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Emergent BioSolutions Inc. (EBS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Emergent BioSolutions Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.